Head of aT1D Early Detection Strategy & Partnerships

Job title: Head  of aT1D Early Detection Strategy & Partnerships

• Location: Bridgewater or Cambridge

• Hybrid Model

• Job type: Permanent, Full-time

About the Job

We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world.

At Sanofi, we are driven by one purpose – we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.

We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Type 1 Diabetes (T1D), which aims to delay the onset of Stage 3 T1D. The onset of Stage 3 T1D can have a major impact for patients and caregivers, including eventually needing insulin for the rest of their lives.  What delayed onset means is more time for patients and caregivers to continue to live without the daily challenges of Stage 3 T1D, including daily use of insulin and monitoring. It gives families and healthcare professionals more time to prepare care plans for a later diagnosis.

Sanofi recognizes that early detection of T1D and risk factors for developing T1D could improve health outcomes for T1D patients.  But many are unaware they are at risk of developing T1D, which highlights the important public health benefits associated with screening – as certain patients who are screened may potentially be appropriate for therapy upon further testing and consultation with their HCP.  Detecting T1D early can prevent years of moderately elevated blood sugar levels and also potentially reduce the risk of going through Diabetic KetoAcidosis (“DKA”), which is a serious complication of diabetes that can lead to hospitalization and be life-threatening.  Undiagnosed T1D can be fatal – and screening can save lives.  It is therefore critical that people be proactively screened to help identify their risk for T1D, before symptoms appear. This is where you come in.

We now present an exciting opportunity for you to go further faster. If you’re excited by the prospect of helping to expand appropriate patient access to autoantibody screening tests, then we want to hear from you as we build a great team who will work to facilitate increased T1D screening for appropriate patients, allowing for early detection, education, and treatment. 

This is a chance to bring your strategic experience, curiosity, problem – solving skills, exceptional people and cross functional leadership energy and expertise to truly transformative and career-defining leadership roles where you can help change countless lives. In return, you will have a rare opportunity in pharma – the chance to help disrupt and delay a debilitating and widespread disease.

This role is critical within the US T1D team and a key =strategic contributor and influencer; this role offering you executive level visibility, dynamic and fast paced challenges, ability to accelerate business transformation and healthcare for patients. You will also partner with key 3rd party screening infrastructure players on strategic opportunities.

Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.

Our Team:

We are seeking a highly strategic, motivated, and visionary leader interested in shaping the identification of people at risk of developing T1D. This individual will be responsible for the development and implementation of the US strategy for accelerated T1D screening across all stakeholders.

They will be expected to collaborate and communicate effectively in a matrix organization with appropriate interactions with Brand Marketing, Sales, Market Research, Human Resources, Medical, Finance, Analytics, Business Operations, Patient Advocacy and Senior North America Leadership.  This role will report to the  Head of the T1D Early Detection.

Your core responsibilities will include:

Role Responsibilities:

• Identify key opportunities and partnerships to improve/simplify T1D screening and monitoring using new diagnostic channels and methodologies, while always ensuring appropriate compliance assessment and validation.

• Responsible for the successful development and execution of the US Accelerated T1D Screening Strategy, resulting in the advancement of an ecosystem to facilitate the integration of T1D screening in routine health care.

• Oversee the execution of the US T1D screening strategy through appropriate collaboration with Marketing, Sales and medical, to effectively drive education, awareness and adoption of T1D screening by HCPs, patients, patient organizations and professional associations.

• Ensure consistency in messaging across external stakeholders, with appropriate partnership within the T1D team.

• (Keep this main bullet, not the sub bullet)Appropriately collaborate with medical, advocacy and other internal/external stakeholders to develop national/regional/local screening programs, screening guidelines & consensus statements.

About you

Experience:

• Bachelor's degree in life sciences or business required; advanced degree preferred.

• At least 10+ years of US leadership experience across commercial or other patient- or HCP-facing organizations with proven track record of success

• Experience building strong partnerships and alliances with screening infrastructure players.

• Prior experience in type 1 diabetes, rare diseases and ideally in screening activities is desired.

• Specialty care experience is a plus.

• Experience in Pediatric and Primary Care markets

• Pharma industry leadership experience required.

Professional skills/behaviors:

• Strong commitment to ethical behavior, integrity and sensitivity to healthcare compliance required.

• Excellent organizational, interpersonal, collaboration and communication skills. Demonstrated ability to communicate effectively with senior leaders.

• Performance orientation and demonstrated ability to deliver along agreed timelines

• Ability to lead in an ambiguous environment across different functions

• Strong strategic thinking skills and prioritizing capacity are required.

• Analytic capabilities with the ability to understand, simplify and communicate effectively with others

• Demonstrated ability to coach, develop and motivate a team

• Readiness to travel (up to 35% of time)

Technical skills:

• Strong background in national health initiatives, or launching products requiring monitoring/screening

• Experience in building partnerships with screening infrastructure players and in developing data-driven solutions, including AI to monitor and identify people at risk

• Experience in product launch & launch excellence

• Languages: Strong communication and presentation skills in English required